Clinical trial
Irinotecan, 5-Fluorouracil, and Leucovorin in Colorectal Carcinoma
NCT00176774 · University of Michigan Rogel Cancer Center, Other · Completed
Key facts
| NCT number | NCT00176774 |
|---|---|
| Title | Irinotecan, 5-Fluorouracil, and Leucovorin in Colorectal Carcinoma |
| Official title | A Pilot Trial of Irinotecan, 5-Fluorouracil, and Leucovorin Combined With the Anti-Angiogenesis Agent Tetrathiomolybdate in Metastatic Colorectal Carcinoma (UMCC 0075) |
| Lead sponsor | University of Michigan Rogel Cancer Center, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Colorectal Carcinoma |
| Intervention type | Drug |
| Interventions | Irinotecan, 5-Fluorouracil, Leucovorin, Tetrathiomolybdate |
| Enrollment | 24 |
| Start date | Feb 1, 2001 |
| Primary completion | Feb 1, 2004 |
| Completion | Apr 1, 2004 |
| First posted | Sep 15, 2005 |
| Last update posted | Feb 7, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: